MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00380-021-02018-3

Медицинская библиотека · Heart and vessels · 2022

Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias.

Schupp Tobias, Ziyadova Sevil, Reinhardt Julius, Sag Yusuf Ugur, von Zworowsky Max, Reiser Linda, Abumayyaleh Mohammad, Weidner Kathrin, Saleh Ahmad, Mashayekhi Kambis, Bertsch Thomas, Abba Mohammed L, Akin Ibrahim, Behnes Michael

СтатьяПеревод пока не подготовлен

Аннотация

The study investigates the prognostic significance of beta-blocker (BB) dose in patients with ventricular tachyarrhythmias. Limited data regarding the prognostic impact of BB dose in ventricular tachyarrhythmias is available. A large retrospective registry was used including consecutive patients on BB treatment with episodes of ventricular tachycardia (VT) or fibrillation (VF) from 2002 to 2015. Discharge BB doses were grouped as > 0-12.5%, > 12.5-25%, > 25-50%, and > 50% according to doses used in randomized trials. The primary endpoint was all-cause mortality at three years. Secondary endpoints comprised of a composite arrhythmic endpoint (i.e., recurrences of ventricular tachyarrhythmias and appropriate ICD therapies) and cardiac rehospitalization. Kaplan-Meier survival curves and multivariable Cox regression analyses were applied for statistics. A total of 1313 patients with BB were included; most patients were discharged with > 25-50% of BB target dose (59%). At three years, > 12.5-25% of BB target dose was associated with improved long-term mortality as compared to the > 0-12.5% group (HR = 0.489; 95% CI 0.297-0.806; p = 0.005), whereas higher BB doses did not improve survival (> 25-50%: HR = 0.849; p = 0.434; > 50%: HR = 0.735; p = 0.285). In contrast, the composite endpoint and risk of rehospitalization were not affected by BB target dose. In conclusion, > 12.5-25% of BB target dose is associated with best long-term survival among patients with ventricular tachyarrhythmias. In contrast, risk of the composite arrhythmic endpoint and risk of cardiac rehospitalization were not affected by BB dose.

Для цитирования: Schupp Tobias, Ziyadova Sevil, Reinhardt Julius, Sag Yusuf Ugur, von Zworowsky Max, Reiser Linda, Abumayyaleh Mohammad, Weidner Kathrin, Saleh Ahmad, Mashayekhi Kambis, Bertsch Thomas, Abba Mohammed L, Akin Ibrahim, Behnes Michael. Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias.. Heart and vessels. 2022. DOI: 10.1007/s00380-021-02018-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.